BLFS
BioLife Solutions Inc
38.50$
-0.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 42.4% | 53.7% | 53.9% | 38.3% | 22.6% | 186.8% | 168.4% | 18.1% | 26.2% | 40.7% | 49.4% | 47.6% | 58.3% | 63.7% | 58.9% | 49.1% | 59.5% | 58.0% | 51.0% | 40.9% | 41.9% | 38.8% | 31.5% | 35.9% | 49.2% | 68.9% | 38.5% | 39.3% | 34.7% | 35.4% | |
| 57.6% | 46.3% | 46.1% | 61.7% | 77.4% | 131.5% | 100.0% | 81.9% | 73.8% | 59.3% | 50.6% | 52.4% | 41.7% | 36.3% | 41.1% | 50.9% | 40.5% | 42.0% | 49.0% | 59.1% | 58.1% | 61.2% | 68.5% | 64.1% | 50.8% | 31.1% | 61.5% | 60.7% | 65.3% | 64.6% | |
| 21.3% | 36.2% | 28.4% | 38.7% | 115.5% | 419.9% | 76.0% | 125.4% | 4.6% | 4.5% | 9.5% | 42.5% | 34.6% | 26.2% | 15.3% | 18.7% | 8.2% | 5.5% | 14.1% | 21.4% | 24.7% | 10.8% | 6.6% | 15.1% | 14.0% | 9.9% | 19.4% | 8.1% | 9.6% | 7.9% | |
| 18.9% | 56.6% | 70.0% | 71.5% | 180.8% | 753.7% | 97.1% | 238.4% | 174.3% | 156.9% | 233,815.1% | 195,639.2% | 165.2% | 119.4% | 72.1% | 66.3% | 38.0% | 30.4% | 64.1% | 75.5% | 55.8% | 41.0% | 30.1% | 32.5% | 30.4% | 28.3% | 43.6% | 62.9% | 49.3% | 47.3% | |
| 47.8% | 92.7% | 98.6% | 126.1% | 318.7% | 1,173.6% | 173.1% | 311.7% | 178.9% | 161.4% | 298.3% | 331.5% | 228.0% | 181.0% | 108.1% | 94.7% | 57.1% | 45.2% | 99.7% | 136.9% | 117.1% | 70.8% | 50.0% | 69.9% | 57.7% | 56.8% | 69.3% | 89.3% | 73.9% | 65.4% | |
| -25.1% | -46.4% | -52.5% | -64.4% | -241.3% | -65.8% | -73.1% | -229.8% | -105.1% | -102.1% | -247.7% | -279.1% | -186.3% | -144.6% | -67.0% | -43.8% | -16.6% | -3.2% | -50.7% | -77.8% | -59.0% | -9.6% | 18.5% | -0.8% | -6.9% | -25.7% | -7.8% | -28.5% | -8.7% | -1.1% | |
| 0.0% | 2.0% | 1.3% | 1.7% | 0.0% | 0.0% | 59.7% | 8.6% | 18.7% | 0.3% | 9.4% | 14.2% | 21.5% | 30.9% | 28.2% | 27.0% | 14.3% | 8.9% | 2.9% | 0.3% | 3.9% | 1.7% | 0.0% | 0.0% | 0.0% | 0.4% | 0.9% | 2.7% | 0.9% | 2.8% | |
| -6.2% | -44.5% | -53.6% | -66.2% | – | -66.0% | -75.2% | -215.3% | -118.6% | -100.7% | -188.0% | -293.3% | -209.8% | -175.0% | -95.3% | -70.9% | -29.3% | -12.1% | -53.3% | -77.5% | -97.7% | -22.8% | 16.5% | -11.7% | -1.2% | -24.4% | -6.4% | -18.0% | -13.9% | -12.6% | |
| 3.1% | -1.9% | 1.0% | 3.5% | -8.2% | 377.7% | -38.8% | -93.1% | 12.7% | -2.2% | -135.9% | 35.2% | 4.5% | -0.4% | 0.1% | 2.8% | 0.0% | 8.9% | -1.4% | -12.8% | 19.7% | 13.2% | 2.0% | -5.6% | -6.8% | -16.9% | -6.9% | -0.1% | 0.0% | 0.1% | |
| -25.0% | -44.5% | -53.5% | -66.2% | -233.0% | -1,044.4% | 25.4% | -215.3% | -118.6% | -100.7% | -188.0% | -293.3% | -209.8% | -175.0% | -95.3% | -70.9% | -29.3% | -12.1% | -52.0% | -65.3% | -83.6% | -22.8% | 16.5% | -6.1% | 5.5% | -7.5% | -183.4% | -100.0% | -24.5% | -12.6% | |
| -22.2% | -34.6% | -38.0% | -48.5% | -218.9% | -63.1% | -53.2% | -188.3% | -78.5% | -91.3% | -239.5% | -275.3% | -184.1% | -138.3% | -63.6% | -40.4% | -13.6% | -0.4% | -46.5% | -72.5% | -89.4% | -6.5% | 20.3% | 9.4% | 5.1% | -14.9% | -4.1% | -10.4% | 1.9% | 3.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.